vacquinol-1   Click here for help

GtoPdb Ligand ID: 8373

Synonyms: NSC13316
Compound class: Synthetic organic
Comment: We represent this molecule with no stereochemical assignments to represent the racemic mixture ariisng from the presence of two steroecentres. The compound can exist as RS (PubChem CID 36691047), SR (PubChem CID 36691042), RR (PubChem CID 36691044) or SS (PubChem CID 3246043) enantiomers. The compound is contained in the National Cancer Institute (NCI) Diversity Set II which is a freely accessible compound repository maintained as part of the Developmental Therapeutics Program (DTP). The DTP provides online, open access to screening data and compound structural details for small molecules that may be of use in anti-cancer (and anti-HIV) drug discovery programmes.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 45.15
Molecular weight 352.13
XLogP 4.58
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(cc1)c1cc(C(C2CCCCN2)O)c2c(n1)cccc2
Isomeric SMILES Clc1ccc(cc1)c1cc(C(C2CCCCN2)O)c2c(n1)cccc2
InChI InChI=1S/C21H21ClN2O/c22-15-10-8-14(9-11-15)20-13-17(16-5-1-2-6-18(16)24-20)21(25)19-7-3-4-12-23-19/h1-2,5-6,8-11,13,19,21,23,25H,3-4,7,12H2
InChI Key VKLJPGAHSLIQKH-UHFFFAOYSA-N
Bioactivity Comments
Vacquinol-1 is reported to selectively reduce viability of patient-derived glioblastoma cells, with an IC50 of 2.36µM [1].